ConductScience.org, home

Paper36744253

Exploration of sodium homeostasis and pharmacokinetics in bile duct-ligated rats treated by anti-cirrhosis herbal formula plus spironolactone.

Hsueh TP and 1 other. Front Pharmacol, 2023. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Exploration of sodium homeostasis and pharmacokinetics in bile duct-ligated rats treated by anti-cirrhosis herbal formula plus spironolactone. Papers, record 36744253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36744253

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploration of sodium homeostasis and pharmacokinetics in bile duct-ligated rats treated by anti-cirrhosis herbal formula plus spironolactone.
PubMed
Journal
Front Pharmacol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.13
iCite
Revised in PubMed
2023-02-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hsueh TPTun-Pin
2Tsai THTung-Hu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117326206The model for end-stage liver disease (MELD).Hepatology2007https://conductscience.org/library/papers/17326206PubMed
227929444Using Light Microscopy and Liquid Chromatography Tandem Mass Spectrometry for Qualitative and Quantitative Control of a Combined Three-Herb Formulation in Different Preparations.Molecules2016https://conductscience.org/library/papers/27929444PubMed
36339312
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Gastroenterology1983https://conductscience.org/library/papers/6339312PubMed
428275293Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases.World J Gastroenterol2017https://conductscience.org/library/papers/28275293PubMed
5477199Renal sodium retention in cirrhosis: relation to aldosterone and nephron site.Clin Sci (Lond)1979https://conductscience.org/library/papers/477199PubMed
630360359Preclinical Pharmacokinetics of Scoparone, Geniposide and Rhein in an Herbal Medicine Using a Validated LC-MS/MS Method.Molecules2018https://conductscience.org/library/papers/30360359PubMed
712830009The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.Hepatology2003https://conductscience.org/library/papers/12830009PubMed
88276370Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.Hepatology1994https://conductscience.org/library/papers/8276370PubMed
934680529The Pharmacological Effects and Pharmacokinetics of Active Compounds of Artemisia capillaris.Biomedicines2021https://conductscience.org/library/papers/34680529PubMed
1019808361Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?Circ Heart Fail2009https://conductscience.org/library/papers/19808361PubMed
1119533820Severe acute cholestatic hepatitis of unknown etiology successfully treated with the Chinese herbal medicine Inchinko-to (TJ-135).World J Gastroenterol2009https://conductscience.org/library/papers/19533820PubMed
1217081806Natural history of patients hospitalized for management of cirrhotic ascites.Clin Gastroenterol Hepatol2006https://conductscience.org/library/papers/17081806PubMed
1317133458Hyponatremia in cirrhosis: Results of a patient population survey.Hepatology2006https://conductscience.org/library/papers/17133458PubMed
147008667Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.Ann Intern Med1981https://conductscience.org/library/papers/7008667PubMed
1522521353Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites.J Hepatol2012https://conductscience.org/library/papers/22521353PubMed
1626223920Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.J Huazhong Univ Sci Technolog Med Sci2015https://conductscience.org/library/papers/26223920PubMed
1726805802Serum Metabolomic Characterization of Liver Fibrosis in Rats and Anti-Fibrotic Effects of Yin-Chen-Hao-Tang.Molecules2016https://conductscience.org/library/papers/26805802PubMed
1825887351Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.BMC Complement Altern Med2015https://conductscience.org/library/papers/25887351PubMed
1929882088Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression.J Cell Commun Signal2019https://conductscience.org/library/papers/29882088PubMed
203333882The metabolism and biopharmaceutics of spironolactone in man.Rev Drug Metab Drug Interact1987https://conductscience.org/library/papers/3333882PubMed

See all 23 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
39081955Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine.Front Pharmacol2024https://conductscience.org/library/papers/39081955

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36744253

GET https://conductscience.org/api/papers/v1/36744253/references?page=2